| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Options Exercise | +3.05K | +35.95% | 11.5K | May 4, 2022 | Direct | F1 | ||
| transaction | OGN | Common Stock | Tax liability | -$33.9K | -1.04K | -9.06% | $32.44 | 10.5K | May 4, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -3.05K | -99.9% | $0.00 | 3.05 | May 4, 2022 | Common Stock | 3.05K | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. |
| F2 | The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. |
| F3 | On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. |